TAP pulls Prevacid television ads

Share this article:
TAP Pharmaceuticals is pulling the plug on television commercials for its heartburn and ulcer treatment Prevacid, instead focusing on the print portion of its campaign for the drug.
TAP spent an estimated $115 million to advertise Prevacid in all major media in 2004, according to Nielsen Monitor-Plus. The sum for TV advertising alone was not available.
A TAP spokeswoman told the New York Times that the drug maker has decided to focus on print advertising because it allows for more detail in describing the drug and gives consumers more time to review information.
A request for further comment from TAP went unreturned at press time.
Merkley & Partners in New York is the lead agency for Prevacid.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.